The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Vittorio Gebbia

Medical Oncology Unit La Maddalena Cancer Clinic

via San Lorenzo Colli n. 312d

90100 Palermo

Italy

[email]@tin.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Medical Oncology Unit La Maddalena Cancer Clinic, via San Lorenzo Colli n. 312d, 90100 Palermo, Italy. 2010 - 2012
  • La Maddalena Clinic for Cancer, Department of Experimental Oncology and Clinical Applications, University of Palermo, Italy. 2003 - 2010
  • Medical Oncology Unit, La Maddalena Hospital, Palermo, Italy. 2007
  • Istituto Clinica Medica, University of Palermo, Palermo, Italy. 2002 - 2003
  • Institute of Internal Medicine, University of Palermo, Via Alessandro Paternostro n 48, 90133 Palermo, Italy. 2003

References

  1. Oral Metronomic Cyclophosphamide with and without Methotrexate as Palliative Treatment for Patients with Metastatic Breast Carcinoma. Gebbia, V., Boussen, H., Valerio, M.R. Anticancer Res. (2012) [Pubmed]
  2. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale. Gebbia, V., Lorusso, V., Galetta, D., Caruso M, M., Palomba, G., Riccardi, F., Borsellino, N., Carrozza, F., Leo, S., Ferraù, F., Cinieri, S., Mancuso, G., Mancarella, S., Colucci, G. Lung. Cancer (2010) [Pubmed]
  3. Irinotecan plus bolus/infusional 5-Fluorouracil and leucovorin in patients with pretreated advanced pancreatic carcinoma: a multicenter experience of the Gruppo Oncologico Italia Meridionale. Gebbia, V., Maiello, E., Giuliani, F., Borsellino, N., Arcara, C., Colucci, G. Am. J. Clin. Oncol. (2010) [Pubmed]
  4. Evolution of therapy decision-making process for advanced non-small cell lung cancer. Gebbia, V., Mancuso, G., Lombardi, L., Maiello, E. Oncology (2009) [Pubmed]
  5. Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer? Gebbia, V. Expert. Opin. Pharmacother (2008) [Pubmed]
  6. Thyroglossal duct cyst carcinoma with concurrent thyroid carcinoma: a case report. Gebbia, V., Di Gregorio, C., Attard, M. J. Med. Case. Reports (2008) [Pubmed]
  7. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale). Gebbia, V., Galetta, D., Lorusso, V., Caruso, M., Verderame, F., Pezzella, G., Borsellino, N., Durini, E., Valenza, R., Agostara, B., Colucci, G. Lung. Cancer (2008) [Pubmed]
  8. Cetuximab in squamous cell head and neck carcinomas. Gebbia, V., Giuliani, F., Valori, V.M., Agueli, R., Colucci, G., Maiello, E. Ann. Oncol. (2007) [Pubmed]
  9. Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. Gebbia, V., Maiello, E., Giuliani, F., Borsellino, N., Caruso, M., Di Maggio, G., Ferraù, F., Bordonaro, R., Verderame, F., Tralongo, P., Di Cristina, L., Agueli, R., Russo, P., Colucci, G. Ann. Oncol. (2007) [Pubmed]
  10. Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience. Gebbia, V., Del Prete, S., Borsellino, N., Ferraù, F., Tralongo, P., Verderame, F., Leonardi, V., Capasso, E., Maiello, E., Bordonaro, R., Stinco, S., Agostara, B., Barone, C. Clin. Colorectal. Cancer (2006) [Pubmed]
  11. Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas. Gebbia, V., Verderame, F., Ferraù, F., Bordonaro, R., Callari, A., Caruso, M., Tirrito, M.L., Valenza, R., Cicero, G., Borsellino, N., Tralongo, P. Ann. Oncol. (2006) [Pubmed]
  12. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM). Gebbia, V., Caruso, M., Borsellino, N., Ajello, R., Tirrito, M.L., Chiarenza, M., Valenza, R., Verderame, F., Varvara, F., Marrazzo, A., Bajardi, E., Ferrao, F., Bordonaro, R., Tralongo, P. Anticancer Res. (2006) [Pubmed]
  13. Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials. Gebbia, V., Galetta, D., De Marinis, F. Ann. Oncol. (2005) [Pubmed]
  14. Oral versus intravenous vinorelbine: clinical safety profile. Gebbia, V., Puozzo, C. Expert. Opin. Drug. Saf (2005) [Pubmed]
  15. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale. Gebbia, V., Galetta, D., Caruso, M., Verderame, F., Pezzella, G., Valdesi, M., Borsellino, N., Pandolfo, G., Durini, E., Rinaldi, M., Loizzi, M., Gebbia, N., Valenza, R., Tirrito, M.L., Varvara, F., Colucci, G. Lung. Cancer (2003) [Pubmed]
  16. Phase I-II parallel study of docetaxel on a bimonthly schedule in refractory metastatic breast carcinoma. Gebbia, V., Borsellino, N., Testa, A., Tirrito, M.L., Ferrera, P., Colombo, A., Mauceri, G., Marrazzo, A., Porretto, F., Musso, M. Breast Cancer Res. Treat. (2003) [Pubmed]
  17. Escalating doses of paclitaxel and epirubicin in combination with cisplatin in advanced ovarian epithelial carcinoma: a phase I-II study. Gebbia, V., Di Marco, P., Borsellino, N., Gebbia, N., Valerio, M.R., Fallica, G., Tirrito, M.L., Valenza, R., Citarrella, P., Benedetti Panici, P. Anticancer. Drugs (2003) [Pubmed]
  18. Systemic chemotherapy in elderly patients with locally advanced and/or inoperable squamous cell carcinoma of the head and neck: impact of anemia and role of recombinant human erythropoietin. Gebbia, V., Di Marco, P., Citarrella, P. Crit. Rev. Oncol. Hematol. (2003) [Pubmed]
  19. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study. Gebbia, V., Galetta, D., Riccardi, F., Gridelli, C., Durini, E., Borsellino, N., Gebbia, N., Valdesi, M., Caruso, M., Valenza, R., Pezzella, G., Colucci, G. Lung. Cancer (2002) [Pubmed]
  20. Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation. Gebbia, V., Mauceri, G., Fallica, G., Borsellino, N., Tirrito, M.L., Testa, A., Varvara, F., Colombo, A., Ferrera, P. Oncology (2002) [Pubmed]
  21. Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix. Gebbia, V., Caruso, M., Testa, A., Mauceri, G., Borsellino, N., Chiarenza, M., Pizzardi, N., Palmeri, S. Oncology (2002) [Pubmed]
 
WikiGenes - Universities